Blinded Independent Central Review (BICR) in New Therapeutic Lung Cancer Trials

Blinded Independent Central Review (BICR) in New Therapeutic Lung Cancer Trials

Background: Double reads in blinded independent central reviews (BICRs) are recommended to control the quality of trials but they are prone to discordances. We analyzed inter-reader discordances in a pool of lung cancer trials using RECIST 1.1. Methods: We analyzed six lung cancer BICR trials that i...

Full description

Bibliographic Details
Main Authors: Hubert Beaumont, Antoine Iannessi, Yi Wang, Charles M. Voyton, Jennifer Cillario, Yan Liu
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
lung cancer
clinical trial
RECIST 1.1
blinded independent central review
Online Access:https://www.mdpi.com/2072-6694/13/18/4533

Internet

https://www.mdpi.com/2072-6694/13/18/4533

Similar Items